Idioma:

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

Galgiani, John N ; Ampel, Neil M ; Blair, Janis E ; Catanzaro, Antonino ; Geertsma, Francesca ; Hoover, Susan E ; Johnson, Royce H ; Kusne, Shimon ; Lisse, Jeffrey ; MacDonald, Joel D ; Meyerson, Shari L ; Raksin, Patricia B ; Siever, John ; Stevens, David A ; Sunenshine, Rebecca ; Theodore, Nicholas

Clinical infectious diseases, 2016-09, Vol.63 (6), p.e112-e146 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por

Enviar para

Título:
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
Autor: Galgiani, John N ; Ampel, Neil M ; Blair, Janis E ; Catanzaro, Antonino ; Geertsma, Francesca ; Hoover, Susan E ; Johnson, Royce H ; Kusne, Shimon ; Lisse, Jeffrey ; MacDonald, Joel D ; Meyerson, Shari L ; Raksin, Patricia B ; Siever, John ; Stevens, David A ; Sunenshine, Rebecca ; Theodore, Nicholas
Assuntos: Antifungal Agents - therapeutic use ; Clinical medicine ; Coccidioidomycosis - diagnosis ; Coccidioidomycosis - epidemiology ; Coccidioidomycosis - physiopathology ; Coccidioidomycosis - therapy ; Compliance ; Fungal infections ; Humans ; Infectious Disease Medicine - organization & administration ; Infectious diseases ; Medical treatment ; Preventive medicine ; United States
É parte de: Clinical infectious diseases, 2016-09, Vol.63 (6), p.e112-e146
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
ObjectType-Feature-2
Descrição: It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. Infectious Diseases Society of America considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.Coccidioidomycosis, also known as San Joaquin Valley fever, is a systemic infection endemic to parts of the southwestern United States and elsewhere in the Western Hemisphere. Residence in and recent travel to these areas are critical elements for the accurate recognition of patients who develop this infection. In this practice guideline, we have organized our recommendations to address actionable questions concerning the entire spectrum of clinical syndromes. These can range from initial pulmonary infection, which eventually resolves whether or not antifungal therapy is administered, to a variety of pulmonary and extrapulmonary complications. Additional recommendations address management of coccidioidomycosis occurring for special at-risk populations. Finally, preemptive management strategies are outlined in certain at-risk populations and after unintentional laboratory exposure.
Editor: United States: Oxford University Press
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

United States: Oxford University Press

Buscando em bases de dados remotas. Favor aguardar.